AssetMark’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
AssetMark's JANX Position: Q3 2026 in Review
AssetMark opened a new position in Janux Therapeutics (JANX) in Q3 2026: 3 shares worth $52. The stake represents ﹤0.01% of the portfolio and ranks #3718 among its holdings.
139 funds tracked by Wall St. Rank hold JANX as of Q3 2026.
- AssetMark held 3 shares of Janux Therapeutics worth $52 as of Q3 2026.
- Janux Therapeutics was a new AssetMark position in Q3 2026.
- Janux Therapeutics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3718 holding.
- 139 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.